Lys370
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Acetylation Site Page: > Lys370  -  p53 (human)

Site Information
RAHsSHLkskkGQst   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 458981

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 8 ) , mass spectrometry ( 7 , 16 ) , mutation of modification site ( 4 , 7 , 8 ) , western blotting ( 8 )
Disease tissue studied:
bone cancer ( 8 ) , colorectal cancer ( 7 ) , colorectal carcinoma ( 7 ) , leukemia ( 16 ) , acute myelogenous leukemia ( 16 ) , lung cancer ( 4 , 7 , 8 ) , non-small cell lung cancer ( 4 , 7 , 8 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Treatments:
nicotinamide ( 7 ) , trichostatin_A ( 7 , 8 )

Downstream Regulation
Effects of modification on biological processes:
apoptosis, induced ( 7 ) , transcription, altered ( 4 , 7 )

References 

1

Zheng S, et al. (2017) Inhibiting p53 Acetylation Reduces Cancer Chemotoxicity. Cancer Res 77, 4342-4354
28655792   Curated Info

2

Seo SK, et al. (2011) Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation. J Thorac Oncol 6, 1313-9
21642861   Curated Info

3

Wu SY, Chiang CM (2009) Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding. EMBO J 28, 1246-59
19339993   Curated Info

4

Tian C, et al. (2009) KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat Cell Biol 11, 580-91
19377469   Curated Info

5

Itahana Y, Ke H, Zhang Y (2009) p53 Oligomerization is essential for its C-terminal lysine acetylation. J Biol Chem 284, 5158-64
19106109   Curated Info

6

Yang W, Wetterskog D, Matsumoto Y, Funa K (2008) Kinetics of repression by modified p53 on the PDGF beta-receptor promoter. Int J Cancer 123, 2020-30
18697203   Curated Info

7

Tang Y, et al. (2008) Acetylation is indispensable for p53 activation. Cell 133, 612-26
18485870   Curated Info

8

Li AG, et al. (2007) An acetylation switch in p53 mediates holo-TFIID recruitment. Mol Cell 28, 408-21
17996705   Curated Info

9

Knights CD, et al. (2006) Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 173, 533-44
16717128   Curated Info

10

Kawaguchi Y, Ito A, Appella E, Yao TP (2006) Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem 281, 1394-400
16291740   Curated Info

11

Luo J, et al. (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A 101, 2259-64
14982997   Curated Info

12

Li M, Luo J, Brooks CL, Gu W (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277, 50607-11
12421820   Curated Info

13

Ito A, et al. (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21, 6236-45
12426395   Curated Info

14

Ito A, et al. (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20, 1331-40
11250899   Curated Info

15

Luo J, et al. (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408, 377-81
11099047   Curated Info

16

Abraham J, Kelly J, Thibault P, Benchimol S (2000) Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry. J Mol Biol 295, 853-64
10656795   Curated Info

17

Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606
9288740   Curated Info